CFH and age-related macular degeneration: Since donors were graded for the presence or absence of AMD and genotyped for CFH Y402H SNP associated with high risk of developing AMD, we were able to perform a comparison of complement and inflammasome-related markers before and after treatment, to determine disease- and genotype-dependent changes.